Pando Bioscience is an AI-driven synthetic biology company revolutionizing enzyme engineering for pharmaceutical manufacturing and diagnostics. By integrating artificial intelligence with an ultra-high-throughput screening platform, Pando accelerates enzyme development, screening 1,000 times more enzymes 75% faster and at 80% lower cost than traditional methods. This approach enables the efficient optimization of enzymes across multiple properties, delivering high-performing, industrial-grade enzymes that create and capture new market value.
Key Features and Functionality:
- AI-Driven Enzyme Engineering: Utilizes generative AI models to design and optimize enzyme sequences, enhancing activity, stability, and manufacturability.
- Ultra-High-Throughput Screening: Employs a proprietary platform capable of screening a vast number of enzyme variants rapidly and cost-effectively.
- Custom Enzyme Solutions: Offers tailored enzyme development services to meet specific client needs in pharmaceutical manufacturing and diagnostics.
- Proprietary Engineered Enzymes: Provides high-performing enzymes designed for molecular biology applications, ensuring superior performance and reliability.
Primary Value and Solutions:
Pando Bioscience addresses the challenges of developing industrial-grade enzymes by significantly reducing the time and cost associated with enzyme optimization. Their AI-guided iterative improvement process ensures enzymes possess a balanced set of properties, such as enhanced activity, stability, and manufacturability. This leads to increased efficiency and profitability for clients in the pharmaceutical and diagnostics industries, enabling them to bring products to market faster and more cost-effectively.